Maria Burian

WORK HISTORY

EDUCATION

ABOUT MARIA BURIAN

Medical Doctor and clinical research leader with extensive experience in neuroscience, pain, inflammatory, and rare diseases, specializing in translational medicine and clinical development. Proven track record of advancing innovative programs from early clinical development through late-phase trials, with a strong focus on delivering meaningful benefit to patients.Led global early-phase clinical programs, including the development of target product profiles and the successful transition of multiple assets into late-stage development across neurology and rare diseases. Extensive experience working with key opinion leaders, regulatory authorities (FDA, EMA), and CRO partners to ensure scientific rigor, regulatory alignment, and high-quality trial execution.Previously drove R&D programs in pain therapeutics, contributing to clinical strategy, product differentiation, and market positioning. Built strong regulatory expertise through direct engagement with health authorities and introduced biomarker-driven strategies to support therapeutic hypothesis validation and translational decision-making.Served on the Steering Committee of a leading international clinical pharmacology society, contributing to the advancement of translational tools, biomarker science, and rare disease research. Supported editorial team of an international journal in Clinical Pharmacology by delivering high-impact peer-reviews of the submitted manuscripts.Thrives in matrixed, multinational environments, combining scientific excellence with strategic leadership and collaborative execution. Passionate about translating innovative science into transformative therapies, with a particular commitment to gene therapy in rare diseases.